Science news articles about 'cml patients'

... will surveying a larger patient sample to determine how frequently this type of resistance develops in CML patients. "The work of [Donato and colleagues] takes us outside of the realm of thoroughly ...

... remains focused on our primary objective of developing omacetaxine as a therapeutic option for CML patients who have developed the T315I mutation and who are resistant to all first and second line ...

... imatinib (Gleevec), a tyrosine kinase inhibitor. “Gleevec does dramatically improve prognosis of CML patients,” notes Pandolfi. “But, unfortunately, Gleevec is not curative in most cases. Because it ...

... -timed vaccine for chronic myelogenous leukemia (CML). The model takes into account the natural anti- ... Kim uses data collected over four years from CML patients during imatinib therapy. "Our results ...

... leukemia cells in the past, is highly expressed in CML stem cells. When Zhou and colleagues blocked ... 1 in cancer cells from imatinib-resistant CML patients, they restored the ability of the drug to kill ...

... -ABL kinase activity is transiently achieved in CML patients treated with dasatinib once daily ... inhibition of BCR-ABL was also effective against CML cells grown in the lab. Significantly, transient ...